Quantitation of irbesartan and major proteins in human plasma by mass spectrometry with time-of-flight analyzer

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 1, 2011, Pages 100-105

  Lu, Chi Yu ^a,b   Feng, Chia Hsien ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiotensin II receptor blocker; Chemical analogues; Irbesartan; MALDI TOF; Nanoliquid chromatography

Indexed keywords

FORMIC ACID; IRBESARTAN; ISOTOPE; LOSARTAN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MONITORING; DRUG STRUCTURE; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICHAEL ADDITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ANGIOTENSIN RECEPTOR ANTAGONISTS; BIPHENYL COMPOUNDS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY; DISULFIDES; HUMANS; MODELS, CHEMICAL; PEPTIDE MAPPING; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TETRAZOLES; TRYPSIN;

EID: 77957046355     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.019     Document Type: Article

References (31)

1. Gilman A.G., Hardman J.G., Limbird L.E. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Ed., Renin and Angiotesin; Antihypertensive Agents and the Drug Therapy of Hypertension 2001, McGraw-Hill Companies, Inc., New York, pp. 809, 871.
2. Waebew B. A review of irbesartan in antihypertensive therapy: comparison with other antihypertensive agents. Curr. Ther. Res. Clin. Exp. 2001, 62:505-523.
3. Whitworth J.A. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003, 21:1983-1992.
4. Najma S., Saeed A.M., Shahid A.S., Shahnawaz S. Simultaneous determination of olmesartan medoxomil and irbesartan and hydrochlorothiazide in pharmaceutical formulations and human serum using high performance liquid chromatography. Chin. J. Chromatogr. 2008, 26:544-549.
5. Erk N. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography. J. Chromatogr. B 2003, 784:195-201.
6. Ferreirós N., Iriarte G., Alonso R.M., Jiménez R.M. Development of a solid phase extraction procedure for HPLC-DAD determination of several angiotensin II receptor antagonists in human urine using mixture design. Talanta 2007, 73:748-756.
7. Caudron E., Laurent S., Billaud E.M., Prognon P. Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography. J. Chromatogr. B 2004, 801:339-345.
8. Ferreirós N., Iriarte G., Alonso R.M., Jiménez R.M., Ortíz E. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method. J. Sep. Sci. 2008, 31:667-676.
9. Nie J., Zhang M., Fan Y., Wen Y., Xiang B., Feng Y.Q. Biocompatible in-tube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine. J. Chromatogr. B 2005, 828:62-69.
10. González L., López J.A., Alonso R.M., Jiménez R.M. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. A 2002, 949:49-60.
11. Chang S.Y., Whigan D.B., Vachharajani N.N., Patel R. High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine. J. Chromatogr. B 1997, 702:149-155.
12. Shakya A.K., Al-Hiari Y.M., Alhamamib O.M.O. Liquid chromatographic determination of irbesartan in human plasma. J. Chromatogr. B 2007, 848:245-250.
13. Bae S.K., Kim M.J., Shim E.J., Cho D.Y., Shon J.H., Liu K.H., Kim E.Y., Shin J.G. HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies. Biomed. Chromatogr. 2009, 23:568-572.
14. Kristoffersen L., Øiestad E.L., Opdal M.S., Krogh M., Lundanes E., Christophersen A.S. Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhythmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry. Method development and robustness testing by experimental design. J. Chromatogr. B 2007, 850:147-160.
15. Lee H.W., Ji H.Y., Park E.S., Lee K.C., Lee H.S. Hydrophilic interaction chromatography-tandem mass spectrometric analysis of irbesartan in human plasma: application to pharmacokinetic study of irbesartan. J. Sep. Sci. 2009, 32:2353-2358.
16. Zhang M., Wei F., Zhang Y.F., Nie J., Feng Y.Q. Novel polymer monolith microextraction using a poly(methacrylic acid-ethylene glycol dimethacrylate) monolith and its application to simultaneous analysis of several angiotensin II receptor antagonists in human urine by capillary zone electrophoresis. J. Chromatogr. A 2006, 1102:294-301.
17. Hillaert S., Van den Bossche W. Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists. J. Chromatogr. A 2002, 979:323-333.
18. Hillaert S., De Beer T.R.M., De Beer J.O., Van den Bossche W. Optimization and validation of a micellar electrokinetic chromatographic method for the analysis of several angiotensin-II-receptor antagonists. J. Chromatogr. A 2003, 984:135-146.
19. Hillaert S., Van den Bossche W. Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal. 2003, 31:329-339.
20. Vetuschi C., Giannandrea A., Carlucci G., Mazzeo P. Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry. Farmaco 2005, 60:665-670.
21. Albero I., Ródenas V., García S., Sánchez-Pedreño C. Determination of irbesartan in the presence of hydrochlorothiazide by derivative spectrophotometry. J. Pharm. Biomed. Anal. 2002, 29:299-305.
22. Abdellatef H.E. Extractive-spectrophotometric determination of disopyramide and irbesartan in their pharmaceutical formulation. Spectrochim. Acta A 2007, 66:1248-1254.
23. Domon B., Aebersold R. Mass spectrometry and protein analysis. Science 2006, 312:212-217.
24. Han X., Aslanian A., Yates J.R. Mass spectrometry for proteomics. Curr. Opin. Chem. Biol. 2008, 12:483-490.
25. Tao W.A., Aebersold R. Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr. Opin. Biotechnol. 2003, 14:110-118.
26. Goshe M.B., Smith R.D. Stable isotope-coded proteomic mass spectrometry. Curr. Opin. Biotechnol. 2003, 14:101-109.
27. Wiese S., Reidegeld K.A., Meyer H.E., Warscheid B. Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research. Proteomics 2007, 7:340-350.
28. Aggarwal K., Choe L.H., Lee K.H. Shotgun proteomics using the iTRAQ isobaric tags. Brief. Funct. Genomic Proteomic 2006, 5:112-120.
29. Zhang G., Neubert T.A. Use of stable isotope labeling by amino acids in cell culture (SILAC) for phosphotyrosine protein identification and quantitation. Methods Mol. Biol. 2009, 527:79-92.
30. Pimienta G., Chaerkady R., Pandey A. SILAC for global phosphoproteomic analysis. Methods Mol. Biol. 2009, 527:107-116.
31. Cagigal E., González L., Alonso R.M., Jiménez R.M. pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry. J. Pharm. Biomed. Anal. 2001, 26:477-486.